Safety Evaluation Of Nivolumab Added Concurrently To Radiotherapy In A Standard First Line Chemo-Rt Regimen In Unresectable Locally Advanced Nsclc: The Etop Nicolas Phase Ii Trial.Solange Peters,Dirk De Ruysscher,Urania Dafni,Enriqueta Felip,Matthias Guckenberger,Johan Vansteenkiste,Rudolf M. Huber,Ernest Nadal-Alforja,Antonio Irigoyen, Annemarie Becker, Anne-Christine Piguet,Marie Kassapian,Adriana Gasca-Ruchti,Alex Martinez Marti,Nicolaus Andratschke,Maarten Lambrecht,Claus Belka, Heidi Roschitzki-Voser,Rolf A. StahelJOURNAL OF CLINICAL ONCOLOGY(2018)引用 29|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要